FibroScan Identifies Patients With Nonalcoholic Fatty Liver Disease and Cardiovascular Damage.
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
27
08
2018
revised:
30
10
2018
accepted:
02
11
2018
pubmed:
12
12
2018
medline:
19
8
2021
entrez:
12
12
2018
Statut:
ppublish
Résumé
Patients with nonalcoholic fatty liver disease (NAFLD), particularly in the presence of nonalcoholic steatohepatitis or fibrosis, are at high cardiac and cerebrovascular risk.
Identifiants
pubmed: 30528844
pii: S1542-3565(18)31254-0
doi: 10.1016/j.cgh.2018.11.011
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
517-519Informations de copyright
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.